E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on

D Dumka1, J Talent, I Akopova

  • 1Univ. of North Texas Health Science Center, Fort Worth, TX 76107, USA. jborejdo@hsc.unt.edu

Insights

The E22K mutation in familial hypertrophic cardiomyopathy does not alter myosin cross-bridge mechanics. Myofibrillar disarray, not the mutation itself, likely explains changes in contraction dynamics.

Area of Science:

  • Cardiovascular Biology
  • Muscle Physiology
  • Molecular Cardiology

Background:

  • Familial hypertrophic cardiomyopathy (HCM) involves cardiac hypertrophy and myofibrillar disarray, often caused by sarcomeric protein mutations.
  • The E22K mutation in the myosin regulatory light chain (RLC) is linked to HCM and affects the RLC's Ca(2+)-binding site.

Purpose of the Study:

  • To investigate the impact of the E22K RLC mutation on the mechanical properties of cardiac myosin cross-bridges during contraction.
  • To determine if the E22K mutation influences myosin head dissociation from actin (tau(1)), cross-bridge rebinding (tau(2)), or ADP dissociation (tau(3)).

Main Methods:

  • Studied transgenic (Tg) mouse cardiac myofibrils with and without the E22K mutation (Tg-m) using single-turnover contraction assays.
  • Measured kinetic parameters (tau(1), tau(2), tau(3)) using actin rotation, anisotropy changes of labeled myosin light chains, and fluorescent ADP binding.
  • Assessed direct myosin-actin binding affinity using fluorescence lifetime and time-resolved anisotropy.

Main Results:

  • The dissociation time of myosin heads from thin filaments (tau(1)) was significantly longer in Tg-m myofibrils compared to controls.
  • Cross-bridge rebinding time (tau(2)) was shorter in Tg-m than non-Tg, but similar to Tg-wild-type (Tg-wt).
  • ADP dissociation time (tau(3)) and direct myosin-actin binding affinity were unaffected by the E22K mutation.

Conclusions:

  • The E22K mutation does not directly alter the intrinsic mechanical properties of cardiac myosin cross-bridges.
  • Increased tau(1) in Tg-m hearts is likely attributable to myofibrillar disarray, a hallmark of HCM.
  • Observed changes in tau(2) may result from the replacement of mouse RLC with the human isoform in Tg mice.

Related Concept Videos

Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...